| 摘要 |
<p>The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of formula I: [I], wherein the radicals and symbols have the meanings as defined in the specification, for the preparation of a medicament for the treatment of Hodgkins disease.</p> |
